<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
p.gmail-m2389624111358285317xmsolistparagraph, li.gmail-m2389624111358285317xmsolistparagraph, div.gmail-m2389624111358285317xmsolistparagraph
{mso-style-name:gmail-m_2389624111358285317xmsolistparagraph;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle23
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:145830116;
mso-list-template-ids:-1759979298;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:2067289969;
mso-list-template-ids:-1062692060;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-GB" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt">***apologies if you receive this more than once***<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-family:"Arial",sans-serif">As part of the recently formed
</span><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.turing.ac.uk%2Fresearch%2Fresearch-projects%2Falan-turing-institute-roche-strategic-partnership&data=04%7C01%7Csdd1%40soton.ac.uk%7C0816523824c542d683bb08d98ca7d7a8%7C4a5378f929f44d3ebe89669d03ada9d8%7C0%7C0%7C637695475677594264%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=E%2B8rm2PNxg306ex5uQlcpTfG8gA1Jks5xFxUC6X61Gw%3D&reserved=0" target="_blank"><span style="font-family:"Arial",sans-serif">Turing-Roche
strategic partnership </span></a><span style="font-family:"Arial",sans-serif">we are thrilled to share an exciting open call to join the partnership expert panel.
</span><o:p></o:p></p>
<p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span style="font-family:"Arial",sans-serif">The Turing has up to 5 roles available at 5% FTE for 12 months. The objectives of the Expert Panel will be to
<span style="color:#2E2E2E">share and discuss ideas, advanced analytics challenges and potential projects and solutions between Turing & Roche as well as, to identify potential projects / areas of interest to be taken to the Partnership Joint Steering Committee.
</span></span><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E"> </span><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E">The panel will also include subject matter experts from across Roche, such as:</span><o:p></o:p></p>
<ul type="disc">
<li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">Diagnostics lead for Data Science Technologies</span><o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">Personalised Health Care Head of Analytics</span><o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">Early Development Director of Digital Pathology</span><o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">Product Development Advanced Analytics Capabilities Lead</span><o:p></o:p></li><li class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">Lead Medical Director</span><o:p></o:p></li></ul>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E">Further information including the role, eligibility, and skills required is available in the attached call document, as well
as on Flexigrant, where the application should be submitted. </span><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E"> </span><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E">Please submit all applications via Flexigrant:
</span><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fati.flexigrant.com%2Fstartapplication.aspx%3Fid%3D8860&data=04%7C01%7Csdd1%40soton.ac.uk%7C0816523824c542d683bb08d98ca7d7a8%7C4a5378f929f44d3ebe89669d03ada9d8%7C0%7C0%7C637695475677594264%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=tuRzOpPCepxWcTsOSMQ0BKyZkF%2Flk65GPRvMQ70XGU4%3D&reserved=0" target="_blank"><span style="font-family:"Arial",sans-serif">Start
an application - The Alan Turing Institute (flexigrant.com)</span></a><span style="font-family:"Arial",sans-serif">.
<span style="color:#2E2E2E">The deadline for applications is <b>Sunday 31<sup>st</sup> October 2021.
</b></span></span><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><b><span style="font-family:"Arial",sans-serif;color:#2E2E2E"> </span></b><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><b><span style="font-family:"Arial",sans-serif;color:#2E2E2E">Should you have any questions, please contact
</span></b><a href="mailto:healthprogramme@turing.ac.uk" target="_blank"><b><span style="font-family:"Arial",sans-serif">healthprogramme@turing.ac.uk</span></b></a><b><span style="font-family:"Arial",sans-serif;color:#2E2E2E">
</span></b><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><b><span style="font-family:"Arial",sans-serif;color:#2E2E2E"> </span></b><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E">Many Thanks</span><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E"> </span><o:p></o:p></p>
<p class="gmail-m2389624111358285317xmsolistparagraph" style="margin:0cm"><span style="font-family:"Arial",sans-serif;color:#2E2E2E">Prof Chris Holmes & Prof Ben MacArthur – on behalf of The Turing-Roche strategic partnership
</span><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</div>
</body>
</html>